Retatrutide has emerged as a new medication in the fight against obesity. This revolutionary drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By activating these receptors, Retatrutide controls cravings, {promotesglucose regulation, and ultimately leads to significant weight loss. While researc